Spray-drying process optimization for manufacture of drugcyclodextrin complex powder using design of experiments

Drug Development and Industrial Pharmacy

Volumn 35, Issue 10, 2009, Pages 1219-1229

  Nekkanti, Vijaykumar ^a   Muniyappan, Thilekkumar ^a   Karatgi, Pradeep ^a   Hari, Molleti Sri ^a   Marella, Seshasai ^a   Pillai, Raviraj ^a  

^a DR REDDY'S LABORATORIES LTD   (India)

Author keywords

Central composite design; Design of experiments; Process optimization; QbD; Spray drying

Indexed keywords

CYCLODEXTRIN;

ARTICLE; CASE REPORT; COMPLEX FORMATION; DRUG MANUFACTURE; HUMAN; MOISTURE; PROCESS OPTIMIZATION; SPRAY DRYING; TEMPERATURE SENSITIVITY;

CHEMISTRY, PHARMACEUTICAL; COMPUTER-AIDED DESIGN; CYCLODEXTRINS; DRUG CARRIERS; DRUG CONTAMINATION; DRUG STABILITY; POWDERS; QUALITY CONTROL; SOLUBILITY; TECHNOLOGY, PHARMACEUTICAL; TEMPERATURE;

EID: 70350672574     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.1080/03639040902882264     Document Type: Article

References (26)

1. Amidon GL, Lennernas H, Shah VP, Crison JR. (1995). A theoretical basis for a biopharmaceutic drug classification: The correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res, 12:413-420
2. Dressman JB, Amidon GL, Reppas C, Shah VP. (1998). Dissolution testing as a prognostic tool for oral drug absorption: Immediate release dosage forms. Pharm Res, 15:11-22.
3. Davis ME, Brewster M. (2004). Cyclodextrin-based pharmaceutics: Past, present and future. Nat Rev Drug Discov, 3:1023-1035
4. Brewster ME, Loftsson T. (2007). Cyclodextrins as pharmaceutical solubilizers. Adv Drug Deliv Rev, 59:645-666
5. Lin SZ, Wouessidjewe D, Poelman MC, Duchene D. (1991). Indomethacin and cyclodextrin complexes. Int J Pharm, 69:211-219
6. Ramprakash G, Nagarsenker MS. (2001). Cyclodextrin based oral delivery of flurbiprofen: Effect of method of preparation on drug release and studies on in-vivo performance. Proceedings of the 28th international symposium on controlled release of bioactive materials and 4th consumer & diversified products conference, vol.28, Controlled Release Society, Inc., San Diego, CA, 772-773
7. Miller LA, Carrier RL, Ahmed I. (2007). Practical considerations in development of solid dosage forms that contain cyclodextrin. J Pharm Sci, 96:1691-1707
8. Sinha VR, Anitha R, Ghosj S, Nanda A, Kumaria R. (2005). Complexation of celecoxib with beta-cyclodextrin: Characterization of the interaction in solution and in solid state. J Pharm Sci, 94:676-687
9. Broadhead J, Edmond Rouan SK, Rhodes CT. (1992). The spray drying of pharmaceuticals. Drug Dev Ind Pharm, 18:1169-1206
10. Muller CR, Bassani VL, Pohlmann AR, Michalowski CB, Petrovick PR, Guterres SS. (2000). Preparation and characterization of spray-dried nanocapsules. Drug Dev Ind Pharm, 26:343-347
11. Desai KGH, Park HJ. (2005). Encapsulation of vitamin C in tripolyphosphate cross-linked chitosan microspheres by spray drying. J Microencapsul, 22:179-192
12. Oakley DE. (1997). Produce uniform particles by spray drying. Chem Eng Prog, 93:48-54.
13. Masters K. (1991). Spray drying handbook. New York: Longman Scientific and Technical.
14. Conte U, Conti B, Giunchedi P, Maggi L. (1994). Spray dried polylactide microsphere preparation: Influence of the technological parameters. Drug Dev Ind Pharm, 20:253-258
15. Wendel S, Celik M. (1997). An overview of spray drying applications. Pharm Technol, 10:124-156
16. Tagne PT, Briancon S, Fessi H. (2006). Spray-dried microparticles containing polymeric nanacapsules: Formulation aspects, liquid phase interactions and particle characteristics. Int J Pharm, 325:63-74.
17. FDA guidance of industry. (2006). ICH Q8 Pharmaceutical development. U.S. Department of Health and Human Services, FDA/ CDER/CBER. http://www.fda.gov/ [accessed April 2, 2009].
18. Billon A, Bataille B, Cassanas G, Jacob M. (2000). Development of spray dried acetaminophen microparticles using experimental designs. Int J Pharm, 203:159-168
19. Vaithiyalingam S, Khan MA. (2002). Optimization and characterization of controlled release multi-particulate beads formulated with a customized cellulose acetate butyrate dispersion. Int J Pharm, 234:179-193 (Pubitemid 34142623)
20. Devay A, Mayer K, Pal S, Antal I. (2006). Investigation on drug dissolution and particle characteristics of pellets related to manufacturing process variables of high-shear granulation. J Biochem Biophys Methods, 69:197-205.
21. Box GEP, Hunter WG, Hunter JS. (1976). Statistics for experimenters, an introduction to design, data analysis, and model building. New York: Wiley.
22. Lieberman HA, Rieger MM, Banker GS. (1988). Pharmaceutical dosage form-Disperse systems. New York: Marcel Dekker, 438-464
23. Giunchedi P, Juliano C, Gavini E, Cossu M, Sorrenti M. (2002). Formulation and in vivo evaluation of chlorhexidine buccal tablets prepared using drug-loaded chitosan microspheres. Eur J Pharm BioPharm, 53:233-239
24. Prinn KB, Costantini RH, Tracy M. (2002). Statistical modeling of protein spray drying at the lab scale. AAPS PharmSciTech, 3:1-8.
25. Martinac A, Filipovic-Grcic J, Perissuti B, Voinivich D, Pavilic Z. (2005). Spray-dried chitosan/ethylcellulose microspheres for nasal drug delivery: Swelling study and evaluation of in vitro drug release properties. J Microencap, 22:549-561
26. Gonnissen Y, Remon JP, Vervaet C. (2008). Effect of maltodextrin and superdisintegrant in directly compressible powder mixtures prepared via co-spray drying. Eur J Pharm BioPharm, 68:277-282